Cleared Traditional

EXTENDSURE HBFASC CONTROL

K053031 · Cantebury Scientific , Ltd. · Hematology
Dec 2005
Decision
41d
Days
Class 2
Risk

About This 510(k) Submission

K053031 is an FDA 510(k) clearance for the EXTENDSURE HBFASC CONTROL, a Control, Hemoglobin, Abnormal (Class II — Special Controls, product code JCM), submitted by Cantebury Scientific , Ltd. (Christchurch, Canterbury, NZ). The FDA issued a Cleared decision on December 7, 2005, 41 days after receiving the submission on October 27, 2005. This device falls under the Hematology review panel. Regulated under 21 CFR 864.7415.

Submission Details

510(k) Number K053031 FDA.gov
FDA Decision Cleared SESE
Date Received October 27, 2005
Decision Date December 07, 2005
Days to Decision 41 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF

Device Classification

Product Code JCM — Control, Hemoglobin, Abnormal
Device Class Class II — Special Controls
CFR Regulation 21 CFR 864.7415

Similar Devices — JCM Control, Hemoglobin, Abnormal

All 11
HEMOGLOBIN F & A2 CONTROL (BETA-THALASSAEMIA CONTROL)
K011389 · Canterbury Health Laboratories · Jun 2001
MODIFICATION TO ABUSCREEN ONLINE FOR PHENCYCLIDINE
K983704 · Roche Diagnostic Systems, Inc. · Feb 1999
QUIK-SEP QUANTITIVE HEMOGLOBIN S CONTROLS
K942222 · Isolab, Inc. · Jan 1995
AFSC HEMO CONTROL #5331, AA2 HEMO CONTROL #5328
K933086 · Helena Laboratories · Oct 1994
HEMOCARD CONTROL HB-AA, AE, FAA, FAE
K931234 · Isolab, Inc. · May 1993
HEMOCARD(TM) CONTROL
K924173 · Isolab, Inc. · Dec 1992